MELIORA 67 LIMITED

Company number 13750434 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

MELIORA 67 LIMITED - Analysis Report

Company Number: 13750434

Analysis Date: 2025-07-20 18:56 UTC

Financial Health Assessment for MELIORA 67 LIMITED


1. Financial Health Score: Grade D

Explanation:
MELIORA 67 LIMITED is currently classified as a dormant company with minimal financial activity over the last financial year. The company’s net assets have dramatically decreased from £4,226 in 2022 to only £3 in 2023, indicating a near lack of operational financial activity. This score reflects a company in financial stasis or very early development stage rather than an active, healthy business generating revenue or profits.


2. Key Vital Signs

Metric 2023 (£) 2022 (£) Interpretation
Current Assets 3 9,791 Cash and short-term assets have nearly depleted.
Current Liabilities Not reported (assumed minimal) 5,565 2023 liabilities not detailed, likely negligible.
Net Current Assets 3 4,226 Working capital essentially non-existent in 2023.
Total Net Assets 3 4,226 Indicates almost no equity left in the company.
Shareholders’ Funds 3 4,226 Reflects shareholders' residual interest—very low now.
Employee Count 0 0 No workforce—consistent with dormant status.
  • Dormant Status: The company has officially filed dormant accounts for the 2022-2023 period, confirming no significant trading or financial transactions.
  • Cash Position: Cash has essentially disappeared from nearly £9,791 to £3, signaling no active cash inflows or outflows.
  • Liabilities: No current liabilities reported in 2023, consistent with dormancy.
  • Equity: The erosion of net assets to near zero suggests no retained earnings or capital injections recently.

3. Diagnosis

MELIORA 67 LIMITED exhibits classic signs of a dormant entity — "clinical inactivity" in financial terms. The company is not currently generating revenue, incurring expenses, or engaging in operational business activities. The drastic drop in current assets and net assets from 2022 to 2023 reflects an absence of trading. The balance sheet shows only nominal residual value, indicating no active business operations or financial health to speak of.

The company’s financial "vital signs" suggest it is not a "living" business in the usual sense but more like a dormant shell, possibly maintained for future use, asset holding, or strategic reasons. There are no symptoms of financial distress such as mounting liabilities or negative working capital, but equally, there are no signs of financial wellness such as healthy cash flow, profitability or asset growth.


4. Recommendations

  • Clarify Business Purpose: If the company is intended to remain dormant, ensure ongoing compliance with Companies House requirements to avoid penalties.
  • Evaluate Strategic Intent: Determine if reactivation or liquidation is appropriate. If reactivation is planned, prepare for capital infusion and operational setup.
  • Financial Planning for Reactivation: Should the company resume trading, establish robust cash flow forecasting, secure working capital, and build a minimal operational budget.
  • Cost Management: Minimize ongoing costs during dormancy to preserve residual equity.
  • Governance: Maintain director oversight to ensure timely filing of accounts and confirmation statements.
  • Consider Liquidation: If the company has no future role or assets and to avoid administrative burden, consider formal closure procedures.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.